These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217 [TBL] [Abstract][Full Text] [Related]
4. Why does diabetes mellitus increase the risk of cardiovascular disease? Shahab A Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030 [TBL] [Abstract][Full Text] [Related]
6. [Endothelial function and the microcirculation in diabetes mellitus]. Arosio E; Minuz P; Prior M Ann Ital Med Int; 1999; 14(2):106-13. PubMed ID: 10399372 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Rask-Madsen C; King GL Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929 [TBL] [Abstract][Full Text] [Related]
9. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Schalkwijk CG; Stehouwer CD Clin Sci (Lond); 2005 Aug; 109(2):143-59. PubMed ID: 16033329 [TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Guerci B; Kearney-Schwartz A; Böhme P; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):425-34. PubMed ID: 11547216 [TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in insulin resistance and type 2 diabetes. Jansson PA J Intern Med; 2007 Aug; 262(2):173-83. PubMed ID: 17645585 [TBL] [Abstract][Full Text] [Related]
12. Lifestyle modification and endothelial function in obese subjects. Hamdy O Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597 [TBL] [Abstract][Full Text] [Related]
13. [Endothelial dysfunction in diabetes]. Nishio Y Nihon Rinsho; 2010 May; 68(5):823-6. PubMed ID: 20446576 [TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Caballero AE Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747 [TBL] [Abstract][Full Text] [Related]
16. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Deedwania PC Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Nathanson D; Nyström T Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307 [TBL] [Abstract][Full Text] [Related]
18. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. Sivitz WI; Wayson SM; Bayless ML; Sinkey CA; Haynes WG J Diabetes Complications; 2007; 21(3):149-57. PubMed ID: 17493547 [TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes. Dandona P; Ghanim H; Chaudhuri A; Mohanty P J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079 [TBL] [Abstract][Full Text] [Related]